This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
Viral infectivity in pediatric SARS-CoV-2 clinical samples does not vary by age
Preprint
in En
| PREPRINT-MEDRXIV
| ID: ppmedrxiv-22281193
ABSTRACT
During the early months of the SARS-CoV-2 pandemic, notable uncertainty emerged regarding the role of children in transmission dynamics 1. With time, it became more clear that children were susceptible to infection with SARS-CoV-2, but that the vast majority of children experienced mild symptoms with lower incidence of severe disease 2. This pattern remained consistent despite the later emergence of SARS-CoV-2 variants, including Delta and Omicron, even among children <5 ineligible for vaccination3. The relative lack of severe disease in the pediatric population raised questions regarding viral kinetics and infectivity in children versus adults.
cc_by_nc_nd
Full text:
1
Collection:
09-preprints
Database:
PREPRINT-MEDRXIV
Type of study:
Observational_studies
/
Prognostic_studies
Language:
En
Year:
2022
Document type:
Preprint